Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Village Clinical Research Inc.
mi
from
New York, NY
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Village Clinical Research Inc.
mi
from
New York, NY
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Richmond Behavioral Associates
mi
from
Staten Island, NY
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Richmond Behavioral Associates
mi
from
Staten Island, NY
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Neuro-Behavioral Clinical Research, Inc.
mi
from
Canton, OH
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Neuro-Behavioral Clinical Research, Inc.
mi
from
Canton, OH
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Midwest Clinical Research Center
mi
from
Dayton, OH
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Midwest Clinical Research Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Cutting Edge Research Group
mi
from
Oklahoma City, OK
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Cutting Edge Research Group
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
IPS Research Company
mi
from
Oklahoma City, OK
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
IPS Research Company
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Oregon Center for Clinical Investigations, Inc.
mi
from
Portland, OR
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Oregon Center for Clinical Investigations, Inc.
mi
from
Portland, OR
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Summit Research Network
mi
from
Portland, OR
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Summit Research Network
mi
from
Portland, OR
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Suburban Research Associates
mi
from
Media, PA
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Suburban Research Associates
mi
from
Media, PA
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Keystone Clinical Studies, Llc
mi
from
Norristown, PA
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Keystone Clinical Studies, Llc
mi
from
Norristown, PA
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Sleep Diagnosists and Treatment Centers
mi
from
West Chester, PA
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Sleep Diagnosists and Treatment Centers
mi
from
West Chester, PA
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Research Strategies of Memphis, LLC
mi
from
Memphis, TN
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Research Strategies of Memphis, LLC
mi
from
Memphis, TN
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
FutureSearch Trials of Dallas, LP
mi
from
Dallas, TX
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
FutureSearch Trials of Dallas, LP
mi
from
Dallas, TX
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Pillar Clinical Research, LLC
mi
from
Dallas, TX
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Pillar Clinical Research, LLC
mi
from
Dallas, TX
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Houston Clinical Trials, LLC
mi
from
Houston, TX
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Houston Clinical Trials, LLC
mi
from
Houston, TX
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Family Psychiatry of the Woodlands
mi
from
The Woodlands, TX
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Family Psychiatry of the Woodlands
mi
from
The Woodlands, TX
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Neuropsychiatric Associates
mi
from
Woodstock, VT
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Neuropsychiatric Associates
mi
from
Woodstock, VT
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
NeuroScience, Inc.
mi
from
Herndon, VA
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
NeuroScience, Inc.
mi
from
Herndon, VA
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Summit Research Network (Seattle) LLC
mi
from
Seattle, WA
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Summit Research Network (Seattle) LLC
mi
from
Seattle, WA
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Dean Foundation
mi
from
Middleton, WI
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Dean Foundation
mi
from
Middleton, WI
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Eastside Therapeutic Resource
mi
from
Middleton, WI
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Eastside Therapeutic Resource
mi
from
Middleton, WI
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Woodhull Medical & Mental Health Center
mi
from
Staten Island, NY
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Woodhull Medical & Mental Health Center
mi
from
Staten Island, NY
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Midwest Research Group
mi
from
Saint Charles, MO
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Midwest Research Group
mi
from
Saint Charles, MO
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Coastal Carolina Research Center
mi
from
Mount Pleasant, SC
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Coastal Carolina Research Center
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Improving Brief Marijuana Interventions With a Behavioral Economic Supplement
Improving Brief Marijuana Interventions With a Behavioral Economic Supplement
Status: Enrolling
Updated:  5/1/2017
University of Memphis
mi
from
Memphis, TN
Improving Brief Marijuana Interventions With a Behavioral Economic Supplement
Improving Brief Marijuana Interventions With a Behavioral Economic Supplement
Status: Enrolling
Updated: 5/1/2017
University of Memphis
mi
from
Memphis, TN
Click here to add this to my saved trials
Risperidone Treatment In Children With Autism Spectrum Disorder And High Levels Of Repetitive Behavior
Risperidone Treatment In Children With Autism Spectrum Disorder And High Levels of Repetitive Behavior
Status: Enrolling
Updated:  5/2/2017
UCLA
mi
from
Los Angeles, CA
Risperidone Treatment In Children With Autism Spectrum Disorder And High Levels Of Repetitive Behavior
Risperidone Treatment In Children With Autism Spectrum Disorder And High Levels of Repetitive Behavior
Status: Enrolling
Updated: 5/2/2017
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Psychopharmacology for Cocaine Dependence - Buspirone
Psychopharmacology of Novel Medications for Cocaine Dependence - Buspirone
Status: Enrolling
Updated:  5/3/2017
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Psychopharmacology for Cocaine Dependence - Buspirone
Psychopharmacology of Novel Medications for Cocaine Dependence - Buspirone
Status: Enrolling
Updated: 5/3/2017
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Citalopram for Cocaine Dependence
Clinical Trial of Serotonin Medication Combination in Cocaine Dependence
Status: Enrolling
Updated:  5/3/2017
UT-Houston Behavioral and Biomedical Sciences Building
mi
from
Houston, TX
Citalopram for Cocaine Dependence
Clinical Trial of Serotonin Medication Combination in Cocaine Dependence
Status: Enrolling
Updated: 5/3/2017
UT-Houston Behavioral and Biomedical Sciences Building
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of SPN-812 ER in Children With ADHD
Status: Enrolling
Updated:  5/4/2017
Florida Clinical Research Center LLC
mi
from
Maitland, FL
Efficacy and Safety of SPN-812 ER in Children With ADHD
Status: Enrolling
Updated: 5/4/2017
Florida Clinical Research Center LLC
mi
from
Maitland, FL
Click here to add this to my saved trials
A Phase I/IIa, Randomized, Double-Blind Study of the Safety and Efficacy of SPN-812 in Adults With ADHD
A Phase I/IIa Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of SPN-812 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/4/2017
Clinical Research Facility
mi
from
Bradenton, FL
A Phase I/IIa, Randomized, Double-Blind Study of the Safety and Efficacy of SPN-812 in Adults With ADHD
A Phase I/IIa Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of SPN-812 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/4/2017
Clinical Research Facility
mi
from
Bradenton, FL
Click here to add this to my saved trials
A Phase I/IIa, Randomized, Double-Blind Study of the Safety and Efficacy of SPN-812 in Adults With ADHD
A Phase I/IIa Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of SPN-812 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/4/2017
Clinical Research Facility
mi
from
Libertyville, IL
A Phase I/IIa, Randomized, Double-Blind Study of the Safety and Efficacy of SPN-812 in Adults With ADHD
A Phase I/IIa Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of SPN-812 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/4/2017
Clinical Research Facility
mi
from
Libertyville, IL
Click here to add this to my saved trials
A Phase I/IIa, Randomized, Double-Blind Study of the Safety and Efficacy of SPN-812 in Adults With ADHD
A Phase I/IIa Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of SPN-812 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/4/2017
Clinical Research Facility
mi
from
Owensboro, KY
A Phase I/IIa, Randomized, Double-Blind Study of the Safety and Efficacy of SPN-812 in Adults With ADHD
A Phase I/IIa Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of SPN-812 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/4/2017
Clinical Research Facility
mi
from
Owensboro, KY
Click here to add this to my saved trials
A Phase I/IIa, Randomized, Double-Blind Study of the Safety and Efficacy of SPN-812 in Adults With ADHD
A Phase I/IIa Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of SPN-812 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/4/2017
Clinical Research Facility
mi
from
Herndon, VA
A Phase I/IIa, Randomized, Double-Blind Study of the Safety and Efficacy of SPN-812 in Adults With ADHD
A Phase I/IIa Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of SPN-812 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/4/2017
Clinical Research Facility
mi
from
Herndon, VA
Click here to add this to my saved trials
Honest Open Proud for Adolescents With Mental Illness
Adaptation and Evaluation of the Honest Open Proud Program for Adolescents With Mental Illness
Status: Enrolling
Updated:  5/8/2017
Illinois Institute of Technology
mi
from
Chicago, IL
Honest Open Proud for Adolescents With Mental Illness
Adaptation and Evaluation of the Honest Open Proud Program for Adolescents With Mental Illness
Status: Enrolling
Updated: 5/8/2017
Illinois Institute of Technology
mi
from
Chicago, IL
Click here to add this to my saved trials
Honest Open Proud for Adolescents With Mental Illness
Adaptation and Evaluation of the Honest Open Proud Program for Adolescents With Mental Illness
Status: Enrolling
Updated:  5/8/2017
Josefinum, Child and Adolescent Psychiatry and Psychotherapy
mi
from
Augsburg,
Honest Open Proud for Adolescents With Mental Illness
Adaptation and Evaluation of the Honest Open Proud Program for Adolescents With Mental Illness
Status: Enrolling
Updated: 5/8/2017
Josefinum, Child and Adolescent Psychiatry and Psychotherapy
mi
from
Augsburg,
Click here to add this to my saved trials
Cognitive-Behavioral Therapy in Veterans With Schizophrenia
Cognitive-Behavioral Therapy in Veterans With Schizophrenia
Status: Enrolling
Updated:  5/9/2017
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
mi
from
West Los Angeles, CA
Cognitive-Behavioral Therapy in Veterans With Schizophrenia
Cognitive-Behavioral Therapy in Veterans With Schizophrenia
Status: Enrolling
Updated: 5/9/2017
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
mi
from
West Los Angeles, CA
Click here to add this to my saved trials
Screening, Brief Intervention, and Referral to Treatment for Offenders
Screening, Brief Intervention, and Referral to Treatment for Offenders
Status: Enrolling
Updated:  5/9/2017
University of California
mi
from
Los Angeles, CA
Screening, Brief Intervention, and Referral to Treatment for Offenders
Screening, Brief Intervention, and Referral to Treatment for Offenders
Status: Enrolling
Updated: 5/9/2017
University of California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Trial of a Novel Cognitive-Behavioral Treatment for Posttraumatic Stress and Substance Dependence
Randomized Controlled Trial of a Novel Cognitive-Behavioral Treatment for Posttraumatic Stress and Substance Dependence
Status: Enrolling
Updated:  5/9/2017
University of Texas Health Science Center at Houston - Center for Neurobehavioral Research on Addiction
mi
from
Houston, TX
Trial of a Novel Cognitive-Behavioral Treatment for Posttraumatic Stress and Substance Dependence
Randomized Controlled Trial of a Novel Cognitive-Behavioral Treatment for Posttraumatic Stress and Substance Dependence
Status: Enrolling
Updated: 5/9/2017
University of Texas Health Science Center at Houston - Center for Neurobehavioral Research on Addiction
mi
from
Houston, TX
Click here to add this to my saved trials
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Status: Enrolling
Updated:  5/10/2017
Children's Hospital Colorado
mi
from
Aurora, CO
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Status: Enrolling
Updated: 5/10/2017
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Status: Enrolling
Updated:  5/10/2017
University of Rochester
mi
from
Rochester, NY
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Status: Enrolling
Updated: 5/10/2017
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Status: Enrolling
Updated:  5/10/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Status: Enrolling
Updated: 5/10/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Status: Enrolling
Updated:  5/10/2017
Hospital for Sick Children
mi
from
Toronto,
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder
Status: Enrolling
Updated: 5/10/2017
Hospital for Sick Children
mi
from
Toronto,
Click here to add this to my saved trials
Family Therapy Via Video Teleconference for Substance-Abusing Rural Adolescents
Family Therapy Via Video Teleconference for Substance-Abusing Rural Adolescents
Status: Enrolling
Updated:  5/11/2017
Oregon Research Institute Center for Family and Adolescent Research
mi
from
Albuquerque, NM
Family Therapy Via Video Teleconference for Substance-Abusing Rural Adolescents
Family Therapy Via Video Teleconference for Substance-Abusing Rural Adolescents
Status: Enrolling
Updated: 5/11/2017
Oregon Research Institute Center for Family and Adolescent Research
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Family-Based Mindful Eating Intervention for Overweight Adolescents
Adaptation and Evaluation of a Family-Based Mindful Eating Intervention for Overweight Adolescents
Status: Enrolling
Updated:  5/11/2017
ORI Center for Family and Adolescent Research
mi
from
Albuquerque, NM
Family-Based Mindful Eating Intervention for Overweight Adolescents
Adaptation and Evaluation of a Family-Based Mindful Eating Intervention for Overweight Adolescents
Status: Enrolling
Updated: 5/11/2017
ORI Center for Family and Adolescent Research
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Central Meditation and Imagery Therapy for Augmentation of Borderline Personality Disorder Treatment
Pilot Study of Central Meditation and Imagery Therapy for Borderline Personality Disorder
Status: Enrolling
Updated:  5/11/2017
University of California at Los Angeles
mi
from
Los Angeles, CA
Central Meditation and Imagery Therapy for Augmentation of Borderline Personality Disorder Treatment
Pilot Study of Central Meditation and Imagery Therapy for Borderline Personality Disorder
Status: Enrolling
Updated: 5/11/2017
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Naltrexone and Memantine Effects on Alcohol Drinking Behaviors
Glutamate-opioid Interactions in Alcohol Drinking Behaviors
Status: Enrolling
Updated:  5/16/2017
Sac, Cmhc
mi
from
New Haven, CT
Naltrexone and Memantine Effects on Alcohol Drinking Behaviors
Glutamate-opioid Interactions in Alcohol Drinking Behaviors
Status: Enrolling
Updated: 5/16/2017
Sac, Cmhc
mi
from
New Haven, CT
Click here to add this to my saved trials
Ambivalence Model of Craving: Re-examining the Drinking-craving Relationship
Ambivalence Model of Craving: Re-examining the Drinking-craving Relationship
Status: Enrolling
Updated:  5/16/2017
University of South Florida
mi
from
Tampa, FL
Ambivalence Model of Craving: Re-examining the Drinking-craving Relationship
Ambivalence Model of Craving: Re-examining the Drinking-craving Relationship
Status: Enrolling
Updated: 5/16/2017
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials